The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries

In the first half of 2021, Israel had been ahead of other countries concerning the speed of its rollout and coverage of COVID-19 vaccinations. During that time, Israel had implemented a vaccine certificate policy, the “Green Pass Policy” (GPP), to reduce virus spread and to allow the safe relaxation...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ruth Waitzberg, Noa Triki, Sharon Alroy-Preis, Tomer Lotan, Liat Shiran, Nachman Ash
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	vaccine certificate COVID-19 public health policy Medicine R
Acceso en línea:	https://doaj.org/article/9dfb79add19644d39935a941e4eedfe9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9dfb79add19644d39935a941e4eedfe9
record_format	dspace
spelling	oai:doaj.org-article:9dfb79add19644d39935a941e4eedfe92021-11-11T16:21:51ZThe Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries10.3390/ijerph1821112121660-46011661-7827https://doaj.org/article/9dfb79add19644d39935a941e4eedfe92021-10-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/21/11212https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601In the first half of 2021, Israel had been ahead of other countries concerning the speed of its rollout and coverage of COVID-19 vaccinations. During that time, Israel had implemented a vaccine certificate policy, the “Green Pass Policy” (GPP), to reduce virus spread and to allow the safe relaxation of COVID-19 restrictions in a time of great uncertainty. Based on an analysis of GPP regulations and public statements compiled from the Israeli Ministry of Health website, we describe the design and implementation of the GPP. We also look back and discuss lessons learned for countries that are considering a GPP policy, given the current upsurge of the Delta variant as of summer 2021. To reduce equity concerns when introducing a GPP, all population groups should be eligible for the vaccine (contingent on approval from the manufacturer) and have access to it. Alternatively, health authorities can grant temporary certificates based on a negative test. We also highlight the fact that in practice, there will be gaps between the GPP regulations and implementation. While some places might require a GPP without legal need, others will not implement it despite a legal obligation. The GPP regulations should have standardised epidemiological criteria, be implemented gradually, remain flexible, and change according to the epidemiological risks.Ruth WaitzbergNoa TrikiSharon Alroy-PreisTomer LotanLiat ShiranNachman AshMDPI AGarticlevaccine certificateCOVID-19public health policyMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11212, p 11212 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	vaccine certificate COVID-19 public health policy Medicine R
spellingShingle	vaccine certificate COVID-19 public health policy Medicine R Ruth Waitzberg Noa Triki Sharon Alroy-Preis Tomer Lotan Liat Shiran Nachman Ash The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries
description	In the first half of 2021, Israel had been ahead of other countries concerning the speed of its rollout and coverage of COVID-19 vaccinations. During that time, Israel had implemented a vaccine certificate policy, the “Green Pass Policy” (GPP), to reduce virus spread and to allow the safe relaxation of COVID-19 restrictions in a time of great uncertainty. Based on an analysis of GPP regulations and public statements compiled from the Israeli Ministry of Health website, we describe the design and implementation of the GPP. We also look back and discuss lessons learned for countries that are considering a GPP policy, given the current upsurge of the Delta variant as of summer 2021. To reduce equity concerns when introducing a GPP, all population groups should be eligible for the vaccine (contingent on approval from the manufacturer) and have access to it. Alternatively, health authorities can grant temporary certificates based on a negative test. We also highlight the fact that in practice, there will be gaps between the GPP regulations and implementation. While some places might require a GPP without legal need, others will not implement it despite a legal obligation. The GPP regulations should have standardised epidemiological criteria, be implemented gradually, remain flexible, and change according to the epidemiological risks.
format	article
author	Ruth Waitzberg Noa Triki Sharon Alroy-Preis Tomer Lotan Liat Shiran Nachman Ash
author_facet	Ruth Waitzberg Noa Triki Sharon Alroy-Preis Tomer Lotan Liat Shiran Nachman Ash
author_sort	Ruth Waitzberg
title	The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries
title_short	The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries
title_full	The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries
title_fullStr	The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries
title_full_unstemmed	The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries
title_sort	israeli experience with the “green pass” policy highlights issues to be considered by policymakers in other countries
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/9dfb79add19644d39935a941e4eedfe9
work_keys_str_mv	AT ruthwaitzberg theisraeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT noatriki theisraeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT sharonalroypreis theisraeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT tomerlotan theisraeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT liatshiran theisraeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT nachmanash theisraeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT ruthwaitzberg israeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT noatriki israeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT sharonalroypreis israeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT tomerlotan israeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT liatshiran israeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries AT nachmanash israeliexperiencewiththegreenpasspolicyhighlightsissuestobeconsideredbypolicymakersinothercountries
_version_	1718432373269331968

The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries

Ejemplares similares